已收录 268921 条政策
 政策提纲
  • 暂无提纲
Bone mineral density, bone remodeling and osteoprotegerin in patients with acute coronary syndrome
[摘要] The objective of this study was to evaluate the relationship between coronary disease and osteoporosis and determine the effect of osteoprotegerin (OPG) on bone remodeling and bone mineral density (BMD) in a group of patients with acute coronary syndrome. Eighty-three patients (52 males and 31 women) with acute coronary syndrome (75 patients with acute myocardial infarction and 8 with unstable angina) with an average age of 61 +/- 10 years were studied. Levels of osteocalcin, urinarydeoxypyridinoline, OPG and the receptor activator of nuclear factor-kappa B ligand (RANKL) were determined during the hospital stay. Femoral neck, trochanter and lumbar spine densitometry was carried out using a DXA densitometer. Thirty percent of patients presented osteoporosis (39% of females and 26% of males). Osteoporotic patients were older and had a lower weight and height and elevated serum levels of osteocalcin (3.6 +/- 2.25 2.63 versus +/- 1.55, p= 0.05). Levels of OPG and RANKL were similar in both groups and showed no relationship with BMD. In conclusion, no relationship was observed between the OPG/ RANKL system and BMD in these patients. (C) 2007 Published by Elsevier Ireland Ltd.
[发布日期] 2008-09-16 [发布机构] 
[效力级别]  [学科分类] 
[关键词] osteoprotegerin;RANKL;osteoporosis;acute coronary syndrome [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文